Conduct secondary research to estimate the epNEC patient population eligible for treatment in 1L and 2L settings. Build a data-driven patient funnel model that progresses from incidence to diagnosis and treatment, tailored to each target market. Triangulate data from multiple sources (e.g., Clarivate, SEER, GLOBOCAN, PubMed, national health agencies). Benchmark estimates using comparable markets to validate findings.